ID   STK31_HUMAN             Reviewed;        1019 AA.
AC   Q9BXU1; B4DZ06; B7WPP5; C9J4F9; Q6PCD3; Q9BXH8;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   12-OCT-2022, entry version 182.
DE   RecName: Full=Serine/threonine-protein kinase 31;
DE            EC=2.7.11.1;
DE   AltName: Full=Serine/threonine-protein kinase NYD-SPK;
DE   AltName: Full=Sugen kinase 396;
DE            Short=SgK396;
GN   Name=STK31; Synonyms=SGK396;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=11279525; DOI=10.1038/86927;
RA   Wang P.J., McCarrey J.R., Yang F., Page D.C.;
RT   "An abundance of X-linked genes expressed in spermatogonia.";
RL   Nat. Genet. 27:422-426(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RA   Zhou Z.M.;
RT   "Cloning of a new protein kinase gene related to human testis
RT   development.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT HIS-71.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-71; PHE-125; LYS-261; ASN-268; LYS-277;
RP   THR-393; GLU-410; PRO-489; THR-600; LYS-621; ILE-623; ARG-684; TYR-684;
RP   LYS-709; LEU-860; MET-1000 AND SER-1010.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BXU1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BXU1-2; Sequence=VSP_024389;
CC       Name=3;
CC         IsoId=Q9BXU1-3; Sequence=VSP_045210;
CC   -!- TISSUE SPECIFICITY: Testis specific.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- CAUTION: Ser-854 is present instead of the conserved Asp which is
CC       expected to be an active site residue. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF285599; AAK31978.1; -; mRNA.
DR   EMBL; AF332194; AAK17193.1; -; mRNA.
DR   EMBL; AK302689; BAG63918.1; -; mRNA.
DR   EMBL; AC003087; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008176; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC059374; AAH59374.1; -; mRNA.
DR   CCDS; CCDS43556.1; -. [Q9BXU1-2]
DR   CCDS; CCDS5386.1; -. [Q9BXU1-1]
DR   CCDS; CCDS59049.1; -. [Q9BXU1-3]
DR   RefSeq; NP_001247433.1; NM_001260504.1. [Q9BXU1-2]
DR   RefSeq; NP_001247434.1; NM_001260505.1. [Q9BXU1-3]
DR   RefSeq; NP_113602.2; NM_031414.4. [Q9BXU1-1]
DR   RefSeq; NP_116562.2; NM_032944.3. [Q9BXU1-2]
DR   AlphaFoldDB; Q9BXU1; -.
DR   BioGRID; 121097; 10.
DR   IntAct; Q9BXU1; 6.
DR   MINT; Q9BXU1; -.
DR   STRING; 9606.ENSP00000348132; -.
DR   BindingDB; Q9BXU1; -.
DR   ChEMBL; CHEMBL6151; -.
DR   GuidetoPHARMACOLOGY; 2220; -.
DR   GlyGen; Q9BXU1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9BXU1; -.
DR   PhosphoSitePlus; Q9BXU1; -.
DR   BioMuta; STK31; -.
DR   DMDM; 143811463; -.
DR   MassIVE; Q9BXU1; -.
DR   MaxQB; Q9BXU1; -.
DR   PaxDb; Q9BXU1; -.
DR   PeptideAtlas; Q9BXU1; -.
DR   PRIDE; Q9BXU1; -.
DR   ProteomicsDB; 5561; -.
DR   ProteomicsDB; 79517; -. [Q9BXU1-1]
DR   ProteomicsDB; 79518; -. [Q9BXU1-2]
DR   Antibodypedia; 12132; 239 antibodies from 28 providers.
DR   DNASU; 56164; -.
DR   Ensembl; ENST00000354639.7; ENSP00000346660.3; ENSG00000196335.13. [Q9BXU1-2]
DR   Ensembl; ENST00000355870.8; ENSP00000348132.3; ENSG00000196335.13. [Q9BXU1-1]
DR   Ensembl; ENST00000433467.6; ENSP00000411852.2; ENSG00000196335.13. [Q9BXU1-3]
DR   GeneID; 56164; -.
DR   KEGG; hsa:56164; -.
DR   MANE-Select; ENST00000355870.8; ENSP00000348132.3; NM_031414.5; NP_113602.2.
DR   UCSC; uc003sws.6; human. [Q9BXU1-1]
DR   CTD; 56164; -.
DR   DisGeNET; 56164; -.
DR   GeneCards; STK31; -.
DR   HGNC; HGNC:11407; STK31.
DR   HPA; ENSG00000196335; Tissue enriched (testis).
DR   MIM; 605790; gene.
DR   neXtProt; NX_Q9BXU1; -.
DR   OpenTargets; ENSG00000196335; -.
DR   PharmGKB; PA36214; -.
DR   VEuPathDB; HostDB:ENSG00000196335; -.
DR   eggNOG; ENOG502QPJA; Eukaryota.
DR   GeneTree; ENSGT00390000007287; -.
DR   HOGENOM; CLU_011956_0_0_1; -.
DR   InParanoid; Q9BXU1; -.
DR   OMA; HRAWNQQ; -.
DR   OrthoDB; 104495at2759; -.
DR   PhylomeDB; Q9BXU1; -.
DR   TreeFam; TF105335; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; Q9BXU1; -.
DR   SignaLink; Q9BXU1; -.
DR   BioGRID-ORCS; 56164; 13 hits in 1103 CRISPR screens.
DR   GenomeRNAi; 56164; -.
DR   Pharos; Q9BXU1; Tchem.
DR   PRO; PR:Q9BXU1; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9BXU1; protein.
DR   Bgee; ENSG00000196335; Expressed in right testis and 102 other tissues.
DR   ExpressionAtlas; Q9BXU1; baseline and differential.
DR   Genevisible; Q9BXU1; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:Ensembl.
DR   CDD; cd04508; TUDOR; 1.
DR   Gene3D; 2.40.50.90; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR035437; SNase_OB-fold_sf.
DR   InterPro; IPR002999; Tudor.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00567; TUDOR; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00333; TUDOR; 1.
DR   SUPFAM; SSF50199; SSF50199; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS50304; TUDOR; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Coiled coil; Kinase; Nucleotide-binding;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..1019
FT                   /note="Serine/threonine-protein kinase 31"
FT                   /id="PRO_0000086715"
FT   DOMAIN          78..137
FT                   /note="Tudor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00211"
FT   DOMAIN          710..1019
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   COILED          298..355
FT                   /evidence="ECO:0000255"
FT   BINDING         716..724
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         737
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         1..23
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_024389"
FT   VAR_SEQ         921..943
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045210"
FT   VARIANT         71
FT                   /note="Q -> H (in dbSNP:rs6945306)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_031600"
FT   VARIANT         125
FT                   /note="S -> F (in dbSNP:rs56268851)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041150"
FT   VARIANT         261
FT                   /note="E -> K (in dbSNP:rs10264952)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_031601"
FT   VARIANT         268
FT                   /note="K -> N (in dbSNP:rs10264967)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_031602"
FT   VARIANT         277
FT                   /note="I -> K (in dbSNP:rs55950645)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041151"
FT   VARIANT         362
FT                   /note="T -> P (in dbSNP:rs35545265)"
FT                   /id="VAR_031603"
FT   VARIANT         385
FT                   /note="R -> C (in dbSNP:rs35995607)"
FT                   /id="VAR_051675"
FT   VARIANT         393
FT                   /note="A -> T (in dbSNP:rs56244148)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041152"
FT   VARIANT         410
FT                   /note="G -> E (in dbSNP:rs4722266)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_031604"
FT   VARIANT         489
FT                   /note="A -> P (in dbSNP:rs34414354)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041153"
FT   VARIANT         600
FT                   /note="A -> T (in dbSNP:rs55796076)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041154"
FT   VARIANT         621
FT                   /note="N -> K (in dbSNP:rs10263079)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041155"
FT   VARIANT         623
FT                   /note="S -> I (in dbSNP:rs10247878)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041156"
FT   VARIANT         684
FT                   /note="H -> R (in dbSNP:rs41273999)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041157"
FT   VARIANT         684
FT                   /note="H -> Y (in a lung neuroendocrine carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041158"
FT   VARIANT         709
FT                   /note="E -> K (in dbSNP:rs56181834)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041159"
FT   VARIANT         860
FT                   /note="V -> L (in a lung small cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041160"
FT   VARIANT         1000
FT                   /note="T -> M (in dbSNP:rs55794023)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041161"
FT   VARIANT         1009
FT                   /note="K -> T (in dbSNP:rs33998018)"
FT                   /id="VAR_031605"
FT   VARIANT         1010
FT                   /note="T -> S (in dbSNP:rs56391043)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041162"
FT   CONFLICT        300
FT                   /note="I -> F (in Ref. 2; AAK17193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        509
FT                   /note="F -> Y (in Ref. 2; AAK17193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        621..623
FT                   /note="NKS -> KKI (in Ref. 1; AAK31978)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        715
FT                   /note="Y -> C (in Ref. 2; AAK17193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        820
FT                   /note="V -> A (in Ref. 2; AAK17193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        948
FT                   /note="K -> I (in Ref. 2; AAK17193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        963
FT                   /note="A -> G (in Ref. 2; AAK17193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1000
FT                   /note="T -> P (in Ref. 2; AAK17193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1010
FT                   /note="T -> P (in Ref. 1; AAK31978)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1019 AA;  115694 MW;  C2EFF005A820E102 CRC64;
     MWVQGHSSRA SATESVSFSG IVQMDEDTHY DKVEDVVGSH IEDAVTFWAQ SINRNKDIMK
     IGCSLSEVCP QASSVLGNLD PNKIYGGLFS EDQCWYRCKV LKIISVEKCL VRYIDYGNTE
     ILNRSDIVEI PLELQFSSVA KKYKLWGLHI PSDQEVTQFD QGTTFLGSLI FEKEIKMRIK
     ATSEDGTVIA QAEYGSVDIG EEVLKKGFAE KCRLASRTDI CEEKKLDPGQ LVLRNLKSPI
     PLWGHRSNQS TFSRPKGHLS EKMTLDLKDE NDAGNLITFP KESLAVGDFN LGSNVSLEKI
     KQDQKLIEEN EKLKTEKDAL LESYKALELK VEQIAQELQQ EKAAAVDLTN HLEYTLKTYI
     DTRMKNLAAK MEILKEMRHV DISVRFGKDL SDAIQVLDEG CFTTPASLNG LEIIWAEYSL
     AQENIKTCEY VSEGNILIAQ RNEMQQKLYM SVEDFILEVD ESSLNKRLKT LQDLSVSLEA
     VYGQAKEGAN SDEILKKFYD WKCDKREEFT SVRSETDASL HRLVAWFQRT LKVFDLSVEG
     SLISEDAMDN IDEILEKTES SVCKELEIAL VDQGDADKEI ISNTYSQVLQ KIHSEERLIA
     TVQAKYKDSI EFKKQLIEYL NKSPSVDHLL SIKKTLKSLK ALLRWKLVEK SNLEESDDPD
     GSQIEKIKEE ITQLRNNVFQ EIYHEREEYE MLTSLAQKWF PELPLLHPEI GLLKYMNSGG
     LLTMSLERDL LDAEPMKELS SKRPLVRSEV NGQIILLKGY SVDVDTEAKV IERAATYHRA
     WREAEGDSGL LPLIFLFLCK SDPMAYLMVP YYPRANLNAV QANMPLNSEE TLKVMKGVAQ
     GLHTLHKADI IHGSLHQNNV FALNREQGIV GDFDFTKSVS QRASVNMMVG DLSLMSPELK
     MGKPASPGSD LYAYGCLLLW LSVQNQEFEI NKDGIPKVDQ FHLDDKVKSL LCSLICYRSS
     MTAEQVLNAE CFLMPKEQSV PNPEKDTEYT LYKKEEEIKT ENLDKCMEKT RNGEANFDC
//
